Currently, the only way for you to receive gene therapy is to participate in a clinical trial. Clinical trials are research studies that help doctors determine whether a gene therapy approach is safe for people. They also help doctors understand the effects of gene therapy on the body.
Your specific procedure will depend on the disease you have and the type of gene therapy being used.
As an example of one type of gene therapy, you may have blood drawn or you may need bone marrow removed from your hipbone with a large needle. Then, in a laboratory, cells from the blood or bone marrow are exposed to a virus or another type of vector that contains the desired genetic material.
Once the vector has entered the cells in the laboratory, those cells are injected back into your body into a vein or into tissue, where your cells take up the vector along with the altered genes.
Viruses aren't the only vectors that can be used to carry altered genes into your body's cells. Other vectors being studied in clinical trials include:
Jan. 05, 2013
- Stem cells. Stem cells are the cells from which all other cells in your body are created. For gene therapy, stem cells can be trained in a laboratory to become cells that can help fight disease.
- Liposomes. These fatty particles have the ability to carry the new, therapeutic genes to the target cells and pass the genes into your cells' DNA.
- Gene therapy. Genetics Home Reference. http://ghr.nlm.nih.gov/handbook/therapy. Accessed Nov. 12, 2012.
- Gene therapy for cancer: Questions and answers. National Cancer Institute. http://cancer.gov/cancertopics/factsheet/Therapy/gene. Accessed Nov. 12, 2012.
- Goldman L, et al. Cecil Medicine. 24th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.mdconsult.com/das/book/body/191371208-2/0/1492/0.html#. Accessed Nov. 12, 2012.
- FAQs. American Society of Gene & Cell Therapy. http://www.asgct.org/general-public/educational-resources/faqs. Accessed Nov. 12, 2012.
- Rivat C, et al. Gene therapy for primary immunodeficiencies. Human Gene therapy. 2012;23:668.
- Garg S. Retinitis pigmentosa: Treatment. http://www.uptodate.com/index. Accessed Dec. 11, 2012.
- Kalos M, et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Science Translational Medicine. 2011;3:1.
- Russell SJ (expert opinion). Mayo Clinic, Rochester, Minn. Dec. 11, 2012.